🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare the efficacy and safety of in...
Status
Not Yet Recruiting
Location
ThirdXiangyaHCSU
Start Date
2026-05-15
Trial ID
NCT07643350
Treatments Being Tested
This clinical trial will evaluate the safety and immune response of the seq...
Status
Completed
Location
University of California at San Francisco
Start Date
2014-09-03
Trial ID
NCT01675765
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of adding th...
Status
Not Yet Recruiting
Location
American University of Beirut
Start Date
2025-04-15
Trial ID
NCT06686381
At present, with the increasing intensities of the tobacco industry and air...
Status
Unknown
Location
The First Hospital of Jilin University
Start Date
2020-08-01
Trial ID
NCT03758677
Treatments Being Tested
This is a multicenter, randomized, blinded, 3-arm Phase 3 study to evaluate...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-06-02
Trial ID
NCT04229615
Treatments Being Tested
This double-blind, placebo-controlled study will evaluate the benefit of fi...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01328951
Treatments Being Tested
This single-arm, open-label, Phase II study assesses first-line QL1706 + be...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021
Start Date
2025-08-01
Trial ID
NCT07083375
Treatments Being Tested
In clinical practice, some patients cannot tolerate concurrent chemoradioth...
Status
Recruiting
Location
Zibo Municipal Hospital
Start Date
2021-05-25
Trial ID
NCT07198217
Treatments Being Tested
Tomivosertib combined with pembrolizumab in Subjects with PD-L1 positive NS...
Status
Unknown
Location
Southern Cancer Center
Start Date
2021-06-02
Trial ID
NCT04622007
Treatments Being Tested
The purpose of this study is to determine the biologically active dose of e...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research
Start Date
2016-12-19
Trial ID
NCT02915523
Treatments Being Tested